HK Stock Market Move | SSY GROUP (02005) fell more than 7%, it is expected that the net profit for the year 2025 will decrease by about 45% to 60% year-on-year.
The Stone Pharmaceutical Group (02005) fell more than 7%, at the time of writing, down 7.28% to HK$2.8, with a turnover of HK$257.58 million.
SSY GROUP (02005) fell by over 7%, as of the time of publication, it fell by 7.28% to HK$2.8, with a turnover of HK$2,575,800.
In terms of news, SSY GROUP announced that it is expecting a 45%-60% decrease in net profit for the fiscal year 2025 compared to the previous year's HK$1.061 billion. This is mainly due to the strong demand for intravenous infusion and other drugs in the first quarter of 2024 due to a domestic flu outbreak, but the overall annual performance for the year ending December 31, 2025 was affected by a decrease in drug sales due to the absence of a large-scale epidemic in the country and cost controls under medical insurance; the expansion of various forms of centralized drug procurement (including national and local alliance procurement) and intensified competition in the industry domestically and abroad leading to continued price pressures; and a decrease in revenue for the bromhexine hydrochloride ampoule injection due to no longer being sold through national centralized drug procurement.
Related Articles

HK Stock Market Move | CNNC INT'L(02302) rises by over 12% again, with a nearly 70% increase in year-to-date. Significant increase in uranium trading volume driving performance.

Over 600 times the safety window, Crystal Taie (02228) empowers Morda Biologics to make a major breakthrough in the development of the world's first oral LDH inhibitor, targeting the billion-dollar self-immune market.

Dispel the rumors! NVIDIA Corporation (NVDA.US) plans to invest $30 billion in OpenAI, with a pre-investment valuation of $73 billion.
HK Stock Market Move | CNNC INT'L(02302) rises by over 12% again, with a nearly 70% increase in year-to-date. Significant increase in uranium trading volume driving performance.

Over 600 times the safety window, Crystal Taie (02228) empowers Morda Biologics to make a major breakthrough in the development of the world's first oral LDH inhibitor, targeting the billion-dollar self-immune market.

Dispel the rumors! NVIDIA Corporation (NVDA.US) plans to invest $30 billion in OpenAI, with a pre-investment valuation of $73 billion.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


